Intelligent Investor

Rhythm Biosciences Limited (ASX: RHY) - Announcements

Current share price for RHY : $0.093 0.001 (1.09%)

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$23 Change in substantial holding - Otto Buttula 2 Apr 2024 9:43AM $0.095 $0.093 $0.095 fallen by 2.11%
$23 Change of Director's Interest Notice - Trevor Lockett 27 Mar 2024 8:38AM $0.093 $0.093 $0.095 fallen by 0%
$23 Change of Director's Interest Notice - Lou Panaccio 27 Mar 2024 8:38AM $0.093 $0.093 $0.095 fallen by 0%
$23 Change of Director's Interest Notice - Otto Buttula 27 Mar 2024 8:37AM $0.093 $0.093 $0.095 fallen by 0%
$23 Ceasing to be a substantial holder 25 Mar 2024 2:23PM $0.093 $0.093 $0.095 fallen by 0%
$23 Distribution schedule - RHYO options 21 Mar 2024 11:01AM $0.097 $0.093 $0.095 fallen by 4.12%
$23 Top 20 securityholders - RHYO options 21 Mar 2024 11:00AM $0.097 $0.093 $0.095 fallen by 4.12%
$23 Update - Application for quotation of securities - RHY 21 Mar 2024 10:56AM $0.097 $0.093 $0.095 fallen by 4.12%
$23 Close of Rights Issue 21 Mar 2024 9:51AM $0.097 $0.093 $0.095 fallen by 4.12%
$23 Application for quotation of securities - RHY 21 Mar 2024 9:47AM $0.097 $0.093 $0.095 fallen by 4.12%
$23 Internationally Renowned Clinical Advisory Board Established 19 Mar 2024 9:22AM $0.095 $0.093 $0.095 fallen by 2.11%
$23 S&P DJI Announces March 2024 Quarterly Rebalance 1 Mar 2024 5:03PM $0.095 $0.093 $0.095 fallen by 2.11%
$23 Half Yearly Report and Accounts 29 Feb 2024 9:50AM $0.098 $0.093 $0.095 fallen by 5.10%
$23 Non-Renounceable Issue - Ineligible Holder Letter 28 Feb 2024 8:31AM $0.100 $0.093 $0.095 fallen by 7%
$23 Dispatch of Rights Issue Offer Prospectus 27 Feb 2024 12:51PM $0.100 $0.093 $0.095 fallen by 7%
$23 Rights Issue Investor Presentation 21 Feb 2024 10:25AM $0.100 $0.093 $0.095 fallen by 7%
$23 PAC Partners Appointed Lead Manager 20 Feb 2024 9:43AM $0.115 $0.093 $0.095 fallen by 19.13%
$23 Rights Issue - Optionholder Letter 19 Feb 2024 5:41PM $0.115 $0.093 $0.095 fallen by 19.13%
$23 Prospectus - 2024 Non-Renounceable Rights Issue 19 Feb 2024 9:31AM $0.135 $0.093 $0.095 fallen by 31.11%
$23 Notification of cessation of securities - RHY 16 Feb 2024 2:43PM $0.120 $0.093 $0.095 fallen by 22.50%
$23 Market Update 16 Feb 2024 9:48AM $0.120 $0.093 $0.095 fallen by 22.50%
$23 Results of Extraordinary General Meeting 12 Feb 2024 1:09PM $0.125 $0.093 $0.095 fallen by 25.60%
$23 EGM Slides 12 Feb 2024 1:05PM $0.125 $0.093 $0.095 fallen by 25.60%
$23 Proposed issue of securities - RHY 9 Feb 2024 10:14AM $0.175 $0.093 $0.095 fallen by 46.86%
$23 Rights Issue Offer to Raise Up To $6.6 million 9 Feb 2024 10:14AM $0.175 $0.093 $0.095 fallen by 46.86%

1 - 25 of 424 results

Page 1 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.